Get started
Author

María Martínez-Roma

Observed names: M. Martínez Roma, Maria Martinez-Roma, Maria Martínez Roma, Martínez-Roma, María, María Martínez Roma
ORCID: 0009-0001-2427-3068
Observed ORCID: 0009-0001-2427-3068
OpenAlex ID: A5075165368
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial
2024 · Meghan E Sise, Jose Ramon Santos, et al. · Clinical Infectious Diseases · 23
Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program
2024 · Enrique Ortega González, María Dolores Ocete Mochón, et al. · International Journal of Infectious Diseases · 14
PDF
Current prevalence of hepatitis delta diagnosis in Valencia, Spain
2025 · Enrique Ortega González, María Dolores Ocete Mochón, et al. · Scientific Reports · 8
HIV screening and linkage to care in a health department in Valencia, Spain: Lessons learned from a healthcare quality improvement project
2022 · Enrique Ortega-Gonzalez, María Martínez-Roma, et al. · Medicine · 8
Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, Spain
2024 · Enrique Ortega, María Dolores Ocete, et al. · Journal of Community Health · 4
PDF
Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme
2025 · E. Ortega González, R. Domínguez-Hernández, et al. · Annals of Epidemiology · 3
Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention
2024 · Inês Vaz-Pinto, Enrique Ortega, et al. · Frontiers in Public Health · 3
PDF
CRIVALVIR-FOCUS: low HIV and chronic Hepatitis B and C infection prevalence among women in reproductive and sexual health services in Valencia, Spain
2022 · Miguel Garcia-Deltoro, Pilar Obon, et al. · Journal of Hepatology
Works count: 9
Citation count: 63
H-index: 4
I10-index: 2
Year
Topic
Type